Physician profile
Basheer Umar Mohammed
NPI 1891373858
$609.45
in general payments reported to CMS, 2019-2025
10 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $117 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.47 |
| Education | $189.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $152.78 | 2025 | Erleada, Akeega, Balversa |
| Astrazeneca Pharmaceuticals Lp | $94.26 | 2025 | Enhertu |
| Incyte Corporation | $89.99 | 2024 | |
| Beone Medicines USA, INC. | $62.63 | 2025 | Brukinsa |
| Intuitive Surgical, INC. | $62.45 | 2025 | |
| Daiichi Sankyo INC. | $48.34 | 2025 | Enhertu, Datroway |
| Beigene USA, INC. | $39.63 | 2025 | Brukinsa |
| Medtronic, INC. | $27.32 | 2024 | Cobalt Dr Mri Surescan |
| Genentech, INC. | $17.60 | 2025 | Tecentriq |
| Terumo Bct, INC. | $14.45 | 2025 | Spectra Optia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basheer Mohammed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.